1. Lee, R., Wong, T. Y. & Sabanayagam, C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis 2, 17 (2015).
2. Diabetic Retinopathy Clinical Research Network, Wells, JA. et al. Aflibercept, bevacizumab or ranibizumab for diabetic macular edema. N Engl J Med 372, 1193–1203 (2015).
3. Virgili, G. et al. Optical coherence tomography (OCT) for detection of macular edema in patients with diabetic retinopathy. Cochrane Database Syst Rev 1, CD008081 (2015).
4. American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern Guidelines. Diabetic Retinopathy. San Francisco, CA. (American Academy of Ophthalmology; available at,
www.aao.org/ppp
. 2016).
5. Olk, R. J. & Lee, C. M. The role of fluorescein angiography in diabetic macular edema. In: Tasman, W & Jaeger, E. Duane’s foundations of clinical Ophthalmology. Chapter 113, Lippincott Williams and Wilkins (1998).